Sunbird Bio
PrivateLast Round
Early Funding
Oct 16, 2024
Total Funding Raised
$36M
Company Overview
Sunbird Bio operates in Healthcare & Life Sciences and is based in Cambridge, Massachusetts. Its latest recorded funding round was an Early Funding round in October 2024.
Sunbird Bio is a biotechnology company that develops proprietary blood-based diagnostic tests to enable earlier, more accurate diagnosis and treatment of neurological disorders and early-stage cancer.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Sunbird Bio Comparables
Compare Sunbird Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| C2N Diagnostics | 82% | |
| ADmit Therapeutics | 79% | |
| ALZpath, Inc. | 79% |
For institutional investors. Book with your work email.
Sunbird Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Oct 16, 2024 | ||||
| M&A | Aug 9, 2023 | ||||
| VC Round | May 12, 2023 | ||||
| Series A | Oct 11, 2018 |
For institutional investors. Book with your work email.
Sunbird Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreatPoint Ventures | Series A |
| S32 | Early Funding |
| ClavystBio | Early Funding |
| EDBI | Early Funding |
| ARCH Venture Partners | Series A |
| Yonghua Capital | Series A |
| Rivas Capital | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2025
Richard Batrla appointed as the new Chief Medical Officer.
- Oct 16, 2024
$14M raised with EDBI and Eli Lilly leading.
For institutional investors. Book with your work email.
Sunbird Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Sunbird Bio's valuation, stock price, and market status.
Is Sunbird Bio a public or private company?
Sunbird Bio is a private company.
What is the current stock price of Sunbird Bio?
Sunbird Bio is a private company, so its shares have no public market price. Caplight tracks Sunbird Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Sunbird Bio worth (valuation)?
Valuation information for Sunbird Bio is not publicly available.
Can I buy Sunbird Bio stock?
Sunbird Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Sunbird Bio's last funding round?
Sunbird Bio's most recent funding round was Early Funding on October 16, 2024.
Who are the main investors in Sunbird Bio?
Key investors in Sunbird Bio include EDBI, ARCH Venture Partners.
Will Sunbird Bio IPO soon?
No public IPO plans have been announced for Sunbird Bio.
How can I track Sunbird Bio secondary market activity?
Caplight tracks bids, offers, and trades in Sunbird Bio's shares on secondary markets.